Position in CHRS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$31,040
-$5,633 QoQ
Shares Held
22,172
+2.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. CHRS ranks #167 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in CHRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,040 | 22,172 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $36,673 | 21,700 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $35,099 | 24,718 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $29,741 | 18,135 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $15,897 | 21,748 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $19,635 | 24,331 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $43,242 | 31,335 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,944 | 27,831 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $36,577 | 21,143 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $63,724 | 26,663 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $78,704 | 23,635 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $71,587 | 19,141 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $76,185 | 17,842 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $108,222 | 15,822 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $140,920 | 17,793 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $157,719 | 16,412 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $116,911 | 16,148 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $289,287 | 22,408 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $431,079 | 27,010 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $420,889 | 26,191 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $443,528 | 32,070 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $404,404 | 27,680 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $440,913 | 25,369 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $362,270 | 19,753 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $361,147 | 20,221 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $215,888 | 13,310 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||